BROOM COLIN MD sold 12.8% of their position (5.34K shares) of NABRIVA THERAPEUTICS PLC on the open market
Open‑market sale worth $1.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/4/2022ACC: 0001104659-22-086280
-5.34K
Net shares
Net seller
$1.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.34K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−5.34K
Price / share
$0.19
Trade value
$1.02K
% of position
12.8%
8/2/2022
41.86K→36.52K
Total
Net shares
−5.34K
Net value
-$1.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/2/2022 | S · Sale | −5.34K | $0.19 | $1.02K | 12.8% | 41.86K | 36.52K |
| Total | −5.34K | -$1.02K | ||||||
Derivative Transactions0
No derivative transactions reported